Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies.
about
Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience.Beta blockers: an innovation in the treatment of infantile hemangiomas.Treatment of infantile haemangiomas: recommendations of a European expert group.Elevated Serum Levels of Alpha-Fetoprotein in Patients with Infantile Hemangioma Are Not Derived from within the TumorIncreasing incidence of infantile hemangiomas (IH) over the past 35 years: Correlation with decreasing gestational age at birth and birth weightEndothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma.Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma: A Randomized Clinical Trial.Long noncoding RNA expression profile of infantile hemangioma identified by microarray analysis.Incidence, Treatment Patterns, and Health Care Costs of Infantile Hemangioma: Results of a Retrospective German Database Analysis.Burden of Infantile Hemangioma on Family: An International Observational Cross-Sectional Study.Ulcerated Scrotal Hemangioma in an 18-Month-Old Male Patient: A Case Report and Review of the Literature.The changing face of complicated infantile hemangioma treatment.Pre-eclampsia and risk of infantile haemangioma.Risk factors and morbidity of infantile haemangioma: preterm birth promotes ulceration.Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey.Expression of Cathepsins B, D, and G in Infantile Hemangioma.Exploring the association between chorangioma and infantile haemangioma in singleton and multiple pregnancies: a case-control study in a Swedish tertiary centre.Circular RNA profile of infantile hemangioma by microarray analysis.Infantile hemangiomas: a 7-year experience of a single-center.Prenatal Risk Factors for PHACE Syndrome: A Study Using the PHACE Syndrome International Clinical Registry and Genetic Repository.Neuropeptide Y receptor 1 is expressed by B and T lymphocytes and mast cells in infantile haemangiomas.Infantile Periocular Haemangioma: Optimising the Therapeutic Response.Association of ATF4 Expression With Tissue Hypoxia and M2 Macrophage Infiltration in Infantile Hemangioma.Classification of Vascular Anomalies: An Update.Current perspectives on the optimal management of infantile hemangioma.Quality of life in children with infantile hemangioma: a case control study.Competitive endogenous RNA networks: integrated analysis of non-coding RNA and mRNA expression profiles in infantile hemangioma.Lesion Morphology in Multifocal Infantile Hemangiomas.Characterisation of lymphocyte subpopulations in infantile haemangioma.Effects of Propranolol on Neurodevelopmental Outcomes in Patients with Infantile Hemangioma: A Case-Control Study.Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment.
P2860
Q33577048-1DED7B83-E5A7-406A-857C-91EBB37E0485Q33931306-E5F496F9-E09E-4E5F-B2B7-6CB143923DF1Q35645474-7F75E753-FE54-420E-AD92-AD65B93FA7BEQ36558970-3B508678-1086-4EA5-9EDD-BB041F511AB3Q37197527-FA807943-14F5-47A1-8F81-00B74A45802CQ37268517-5DCC3F0D-B5D5-4427-A144-79006D32DBBBQ38377887-DED2331A-BE98-4F35-B812-87F620F8ECA4Q38442054-5F55100C-3659-4054-83D1-401539965957Q38694569-201393CB-BC4A-4330-9CDA-4580EDF0A2C0Q38734281-67325422-7E6E-4823-B568-8C9B553D6C14Q38896141-5FBEB4DB-21A7-4955-BC9B-FFB595EE9BC5Q38906330-FA897FFB-9D02-4971-A55D-515A02AA40B3Q39499343-1A58F695-9804-4E6F-8806-1919E761AE33Q39794295-7CE3DEF3-36C4-4FC8-A279-0D37C34F8BC7Q40424734-E8BE0483-BEFB-4A77-945E-ED44E23AF555Q40773699-34115A2B-4872-432A-A458-ED78B6F0985AQ41581678-24253C26-F99B-48DA-8D0D-62AF6660A83AQ45374813-1A99CB0D-2D62-44AD-83D1-9A38FF1686A6Q45381729-EEDCC48B-D7EE-49F8-A9A2-933E7074EE34Q46104048-AD18FC7E-E592-4E34-8005-50ED49A078E3Q47849205-6849FCA2-37F6-47E3-808C-775D9C3C8657Q47871326-A90E0492-75A6-4C1D-A57A-B2A03878151AQ47911411-FBFEF25E-335E-4CD7-92C1-4E3458AEC580Q48514331-D5788B98-5D86-410C-A10C-BC48151EC4FAQ49297431-B4DEB25C-9EA8-459C-814B-429A72894408Q49308699-297DD134-AF0A-4E3E-9033-E8208E703C41Q52351074-35A409E2-63BF-44CA-A57F-28EB33872C06Q53033140-D29A84AD-6FA7-40BC-BA98-1045523347D0Q53469895-4AA9124D-0EF7-450D-A2EE-693DDFF550B6Q55266898-45524248-47F1-4E0D-ACDC-3E3D366757BDQ55394881-20D85BCF-628C-4EBB-A0B4-C4F7C4416351
P2860
Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prospective study of infantile ...... tion with placental anomalies.
@ast
Prospective study of infantile ...... tion with placental anomalies.
@en
type
label
Prospective study of infantile ...... tion with placental anomalies.
@ast
Prospective study of infantile ...... tion with placental anomalies.
@en
prefLabel
Prospective study of infantile ...... tion with placental anomalies.
@ast
Prospective study of infantile ...... tion with placental anomalies.
@en
P2093
P2860
P356
P1476
Prospective study of infantile ...... tion with placental anomalies.
@en
P2093
D F Friedlander
D M Poeltler
J S Marshall
M Friedlander
R Butschek
P2860
P304
P356
10.1111/BJD.12804
P407
P577
2014-04-01T00:00:00Z